Dupixent and Yellow skin - a phase IV clinical study of FDA data
Yellow skin is found among people who take Dupixent, especially for people who are male, 20-29 old, have been taking the drug for 1 - 2 years.
The phase IV clinical study analyzes which people take Dupixent and have Yellow skin. It is created by eHealthMe based on reports of 125,036 people who have side effects when taking Dupixent from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
125,036 people reported to have side effects when taking Dupixent.
Among them, 9 people (0.01%) have Yellow skin.
What is Dupixent?
Dupixent has active ingredients of dupilumab. eHealthMe is studying from 70,512 Dupixent users for its effectiveness, alternative drugs and more.
What is Yellow skin?
Yellow skin is found to be associated with 1,410 drugs and 1,021 conditions by eHealthMe.
Number of Dupixent and Yellow skin reports submitted per year:
Time on Dupixent when people have Yellow skin *:
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 100 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Yellow skin when taking Dupixent *:
- female: 37.5 %
- male: 62.5 %
Age of people who have Yellow skin when taking Dupixent *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 40 %
- 20-29: 40 %
- 30-39: 0.0 %
- 40-49: 20 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common side effects people have besides Yellow skin *:
- Rashes (redness): 2 people, 22.22%
- Peripheral Coldness: 2 people, 22.22%
- Varices Oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach): 1 person, 11.11%
- Sunburn: 1 person, 11.11%
- Skin Swelling: 1 person, 11.11%
- Skin Exfoliation (removal of the oldest dead skin cells): 1 person, 11.11%
- Rash Papular (redness with papule): 1 person, 11.11%
- Limb Injury: 1 person, 11.11%
- Hepatic Steatosis (fatty liver disease): 1 person, 11.11%
- Head Injury: 1 person, 11.11%
Common conditions people have *:
- Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 7 people, 77.78%
- Asthma: 1 person, 11.11%
* Approximation only. Some reports may have incomplete information.
Do you take Dupixent and have Yellow skin?Check whether Yellow skin is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Yellow skin and when was it recovered:
Expand to all the drugs that have ingredients of dupilumab:
Alternative drugs to, pros and cons of Dupixent:
- Dupixent (70,512 reports)
Common Dupixent side effects:
Browse all side effects of Dupixent:a b c d e f g h i j k l m n o p q r s t u v w x y z
Yellow skin treatments and more:
- Yellow skin (4,997 reports)
COVID vaccines that are related to Yellow skin:
- Yellow skin in Moderna COVID Vaccine
- Yellow skin in Pfizer BioNTech Covid Vaccine
- Yellow skin in Johnson and Johnson Covid Vaccine
Common drugs associated with Yellow skin:
All the drugs that are associated with Yellow skin:
- Yellow skin (1,410 drugs)
Common conditions associated with Yellow skin:
All the conditions that are associated with Yellow skin:
- Yellow skin (1,021 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on dupilumab (the active ingredients of Dupixent) and Dupixent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Varicose Vein in Lisinopril, how severe and when it was recovered? - now
- Renal Abscess and drugs of ingredients of crizotinib - 3 seconds ago
- Nightmares in Papa-Deine #3, how severe and when it was recovered? - 3 seconds ago
- Sucralfate and Disease Progression - 5 seconds ago
- Descovy and Basaglar drug interaction - 8 seconds ago
- Glimepiride and Tonsillitis - 11 seconds ago
- Rebif and Lamisil drug interaction - 17 seconds ago
- Tapentadol and Weight Loss - 27 seconds ago
- Aldactone and Keloids - 27 seconds ago
- High Blood Cholesterol and drugs of ingredients of peginterferon alfa-2a; ribavirin - 29 seconds ago